Showing results (1081-1090 of 1,132) with videos related to

Sort By:
Pageof 114
Atmospheric Chemistry and Physics|January 28, 2025
Linking gas, particulate, and toxic endpoints to air emissions in the Community Regional Atmospheric Chemistry Multiphase Mechanism (CRACMM)Havala O T Pye, Bryan K Place, Benjamin N Murphy, et al.
Science Translational Medicine|February 18, 2021
Platelets release mitochondrial antigens in systemic lupus erythematosusImene Melki, Isabelle Allaeys, Nicolas Tessandier, et al.
European Urology Focus|November 5, 2021
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian CentersAlice Dragomir, Sara Nazha, Simon Tanguay, et al.
European Urology Oncology|December 14, 2023
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic TherapiesGhady Bou-Nehme Sawaya, Alice Dragomir, Lori A Wood, et al.
Clinical Genitourinary Cancer|April 27, 2025
Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World StudyGhady Bou-Nehme Sawaya, Simon Tanguay, Lori A Wood, et al.
Clinical Genitourinary Cancer|March 6, 2026
Node Positive Resected Renal Cell Carcinoma Portends a Poor Prognosis: Results From the Canadian Kidney Cancer CollaborationJesse Tr Spooner, Christopher Bitcon, Wyatt MacNevin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information systemRyan Sun, Rodney H Breau, Ranjeeta Mallick, et al.
European Urology|July 17, 2022
Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell CarcinomaJens Bedke, Brian I Rini, Elizabeth R Plimack, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 6, 2019
Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective DatabaseI Kushnir, L Kirk, R Mallick, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis DatabaseChangsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh, et al.
Pageof 114